GGrantIndex
Sort

39,280 grants matching leukemia

Function of MEF in Hematopoietic Cells

$331,216
Sloan-Kettering Institute For Cancer Res · R01 · FY2003 · DK

GENETIC ANALYSIS OF MYELOPROLIFERATIVE DISEASE

$331,177
Roswell Park Cancer Institute Corp · R01 · FY2003 · CA

Project 3: Modeling Malignant Myelopoiesis to Increase Efficacy of Targeted Leukemia Therapy

$331,159
Richard A. Van Etten · University Of California-Irvine · U54 · FY2018 · CA

Genomics of AML Relapse

$331,123
John F Dipersio · Washington University · P01 · FY2013 · CA

Validating Syk as a Target for AML Therapy

$331,098
Kimberly Stegmaier · Dana-Farber Cancer Inst · R01 · FY2013 · CA

NOVEL GENE REARRANGED WITH THE RAR ALPHA LOCUS

$331,090
Mount Sinai School Of Medicine Of Nyu · R01 · FY2001 · CA

Study DNA repair in preventing MDS and AML after radiation and benzene exposure

$331,070
Edward P Hasty · University Of Texas Hlth Science Center · R01 · FY2014 · ES

Development of AMPK Inhibitors for the treatment of leukemia

$331,069
Philip Reigan · University Of Colorado Denver · R01 · FY2022 · CA

Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy

$331,066
Evripidis Gavathiotis · Albert Einstein College Of Medicine, Inc · R01 · FY2018 · CA

Prevention of quinone toxicity and mutagenicity

$331,034
Anil Kumar Jaiswal · University Of Maryland Baltimore · R01 · FY2009 · ES

Prevention of quinone toxicity and mutagenicity

$331,034
Anil Kumar Jaiswal · University Of Maryland Baltimore · R01 · FY2008 · ES

Polymorphism of Multi-Drug-Resistance Protein-1

$331,031
University Of Washington · R01 · FY2005 · GM

PROJECT ALLIFE-EXERCISE AND LEUKEMIA SURVIVORS

$330,998
Kevin Charles Oeffinger · Sloan-Kettering Inst Can Research · R01 · FY2006 · CA

CO-FACILITATORS: NOVEL REGULATORS OF HORMONE METABOLISM

$330,960
Cedars-Sinai Medical Center · R01 · FY2001 · DK

RhoH GTPase in Hematopoiesis and Cancer

$330,957
David A Williams · Boston Children'S Hospital · R01 · FY2010 · CA

Mechanisms of Kinase Function and Drug Resistance in Cancer

$330,942
Karsten Sauer · Scripps Research Institute, The · R01 · FY2013 · GM

Role of POZ-zinc finger proteins in tumorigenesis.

$330,937
Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R01 · FY2012 · CA

Role of POZ-zinc finger proteins in tumorigenesis.

$330,937
Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R01 · FY2011 · CA

WUMC Cancer and Leukemia Group B

$330,937
Nancy L Bartlett · Washington University · U10 · FY2011 · CA

Advancing the cloud-based data access and interoperability infrastructure of the INCLUDE data ecosystem

$330,890
Adam Cain Resnick · Children'S Hosp Of Philadelphia · U2C · FY2022 · HL

Role of MN1-TEL and MN1 in Leukemogenesis

$330,885
Gerard C Grosveld · St. Jude Children'S Research Hospital · R01 · FY2006 · CA

Role of miR155 in Leukemogenesis

$330,797
Carlo M Croce · Ohio State University · R01 · FY2009 · CA

MLL in maintenance and regulation of HOX gene expression

$330,784
Nancy J Zeleznik-Le · Loyola University Chicago · R01 · FY2012 · HL

GENE EXPRESSION BY HUMAN GRANULOCYTIC EHRLICHIOSIS AG

$330,750
Ohio State University · R01 · FY2004 · AI

Optimization of gene transfer and gene editing safety and efficacy focusing on the NHP model

$330,728
Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL